The number of active shortages of generic drugs in the US has reached its highest level since 2001, according to the American Society of Health-System Pharmacists. This calls for increased efforts from Congress and federal agencies to address the broken market. Proposed measures include rewarding hospitals for maintaining an adequate supply of key drugs and establishing buffer stocks of essential medicines for small hospitals.
Share on linkedin Data: American Society of Health-System Pharmacists; Note: Each point represents the number of active shortages at the end of each quarter; Chart: Axios Visualshave risen to their highest level since the American Society of Health-System Pharmacists began tracking in 2001.This high-water mark should energize efforts in Congress and federal agencies to address the broken market around what are often critical generic drugs , the organization says.
Drugmakers that can demonstrate safer, higher-quality manufacturing practices should earn a higher price, he said. Manufacturing quality concerns in particular have fueled shortages of chemotherapy drugs and some antibiotics.Controlled substances, such as pain and sedation medications,12% of active shortages, which are tied to recent legal settlements and Drug Enforcement Administration changes to production limits, per ASHP.
Not surprisingly, the blockbuster category of anti-obesity drugs known as GLP-1s are in shortage largely because of outsized demand.
Generic Drugs Shortages American Society Of Health-System Pharmacists Congress Federal Agencies Hospitals Buffer Stock Transparency Quality Manufacturing Practices
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2 arrested in Lake Havasu City after police find meth, illegal drugs within reach of childShayna Feinman’s family is desperate for answer after the woman went missing more than two weeks ago.
Read more »
Weight loss drugs Wegovy and Zepbound remain out of reach for many who need themBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
America's life-threatening drug shortages reach record highsLast year, Americans spent over $600 billion on prescription drugs. That's more than ever before -- and more than any other country in the world.
Read more »
How a cheap, generic drug became a darling of longevity enthusiastsRapamycin, a drug for transplant patients, has extended the lives of animals but is unproven in humans. That hasn’t stopped people from trying it.
Read more »
How a cheap, generic drug became a darling of longevity enthusiastsRapamycin, a drug for transplant patients, has extended the lives of animals but is unproven in humans. That hasn’t stopped people from trying it.
Read more »
'Arthur the King' review: A rather generic underdog storyMark Wahlberg plays an adventure racer who befriends a dog on a 435 mile trek through the jungle in “Arthur the King.' It's based on the true story of Mikael Lindnord who wrote a book about the experience and started a foundation for animals afterwards.
Read more »